CRB Bio II and ADE Capital Sodical Commits €3M Seed Investment Round

News   Jul 08, 2013

 
CRB Bio II and ADE Capital Sodical Commits €3M Seed Investment Round
 
 
 

RELATED ARTICLES

Possible Biomarker to Identify Who Would Benefit from Immunotherapy

News

While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. In a new study, researchers examined tissue samples from melanoma and ovarian cancer patients treated with immunotherapies and found a link between the percentage of antigen-presenting cells expressing PD-L1 and an objective clinical response to treatment.

READ MORE

Longevity Protein Could Help Treat Diabetes

News

beta-Klotho, a protein that regulates longevity, could have therapeutic potential for diabetes and obesity.

READ MORE

Raman Spectroscopy Aids Advancement of Spintronic Devices

News

Researchers used an unconventional approach, employing Raman spectroscopy with an ultraviolet laser instead of conventional visible light lasers, to improve understanding of nickel oxide crystals. This work could have important implications for development of spintronic devices for memory storage and information processing.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE